Literature DB >> 27201103

Regulatory Approval To Patient Access, An Evaluation of Eu5 And Us National Timing Differences: An Update.

J Mycka1, R Dellamano2, W Lobb1, N Dalal1, E Pereira1, L Dellamano2, O Sagaydachnaya1.   

Abstract

Entities:  

Year:  2014        PMID: 27201103     DOI: 10.1016/j.jval.2014.08.1075

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Developing a model of a patient-group pathway to accessing cancer clinical trials in Canada.

Authors:  G Batist; S Michaud; D P Richards; F Servidio-Italiano; B D Stein
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.